Search
INNO-305
go.drugbank.com/drugs/DB06025InvestigationalINNO-305 is an investigational vaccine developed by Innovive Pharmaceuticals for the treatment of patients with acute myeloid leukemia in complete remission.
Ruplizumab
go.drugbank.com/drugs/DB06475InvestigationalRuplizumab is a humanized monoclonal antibody used as an immunosuppressive drug and is a component of Antova.
Methyl salicylate 2-ethylbutyrate
go.drugbank.com/drugs/DB14130InvestigationalMixtures: Thera Derm Roll OnAmdizalisib
go.drugbank.com/drugs/DB21514InvestigationalAmdizalisib has a monoisotopic molecular weight of 390.11 Da. … Amdizalisib is under investigation in clinical trial NCT05713110 (A Study of Tazemetostat in Combination With HMPL-689 in Patients With Relapsed/Refractory Lymphoma).
ATHX-105
go.drugbank.com/drugs/DB06008InvestigationalATHX-105 is an investigational selective 5HT2c receptor agonist developed by Athersys Inc. for the treatment of Obesity.
Emeramide
go.drugbank.com/drugs/DB12192InvestigationalEmeramide has been used in trials studying the treatment of Mercury Poisoning.
Categories: Compounds used in a research, industrial, or household settingMevidalen
go.drugbank.com/drugs/DB19034InvestigationalMevidalen is under investigation in clinical trial NCT03305809 (A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or
Nizaracianine
go.drugbank.com/drugs/DB21517InvestigationalNizaracianine has a monoisotopic molecular weight of 942.43 Da. … Nizaracianine is under investigation in clinical trial NCT05752149 (Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial).